GGHC
CDNA icon

Gilder Gagnon Howe & Co’s CareDx CDNA Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-83,112
Closed -$2.99M – 288
2019
Q2 		$2.99M Sell
83,112
-36,453
-30% -$1.17M 0.03% 198
2019
Q1 		$3.77M Sell
119,565
-42,322
-26% -$1.23M 0.04% 183
2018
Q4 		$4.07M Sell
161,887
-518
-0.3% -$13.3K 0.06% 165
2018
Q3 		$4.68M Buy
+162,405
New +$3.04M 0.05% 181

Other funds holding CDNA

FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Gilder Gagnon Howe & Co's CDNA Position: Q3 2019 in Review

Gilder Gagnon Howe & Co sold out of CareDx (CDNA) in Q3 2019, closing a stake of 83,112 shares — an estimated $2.99M sold.

Gilder Gagnon Howe & Co first reported a position in CDNA in Q3 2018 and held it in 4 quarters. The position peaked at $4.68M in Q3 2018. 174 funds tracked by Wall St. Rank hold CDNA as of Q3 2019.

  • Gilder Gagnon Howe & Co reported no remaining CareDx position as of Q3 2019 after selling out during the quarter.
  • Gilder Gagnon Howe & Co sold 83,112 CareDx shares in Q3 2019, an estimated $2.99M.
  • Gilder Gagnon Howe & Co first reported a position in CareDx in Q3 2018 and held it in 4 quarters.
  • Gilder Gagnon Howe & Co's CareDx position peaked at $4.68M in Q3 2018.
  • 174 funds tracked by Wall St. Rank held CareDx as of Q3 2019.

Based on Gilder Gagnon Howe & Co's 13F filing for Q3 2019, filed 14 Nov 2019.